Tag: pain management

Dr. Reddy’s Laboratories launches migraine management wearable Nerivio in Germany

businessnewstoday- April 10, 2024

In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry, has announced the launch of its groundbreaking, ... Read More

Avanos Medical to acquire pain management innovator Diros Technology

businessnewstoday- June 20, 2023

In a decisive move to enhance its chronic pain management solutions, US-based medical technology firm Avanos Medical has announced plans to acquire Diros Technology, a ... Read More

Home remedies for Arthritis: Natural ways to manage joint inflammation

businessnewstoday- May 28, 2023

Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies ... Read More

Dr. Reddy’s to sell and distribute certain Novartis’ products in India

pallavi123- February 11, 2022

Dr. Reddy's Laboratories has signed an exclusive sales and distribution agreement with Novartis India Limited (NIL) for the latter’s Voveran range, the Calcium range and ... Read More

Dr. Reddy’s to acquire German medical cannabis firm Nimbus Health

pallavi123- February 7, 2022

Dr. Reddy’s Laboratories has agreed to acquire Nimbus Health, a German medical cannabis firm, for an undisclosed price. The Indian pharma company will acquire Nimbus ... Read More

Venus Remedies forays into consumer healthcare market with R3SET Life

pallavi123- July 15, 2021

Venus Remedies, a Chandigarh-based pharma company, has forayed into the Indian consumer healthcare market, with the launch of R3SET, a holistic pain management solution. According ... Read More

Reckitt Benckiser to acquire Biofreeze pain relief brand from Performance Health

pallavi123- February 24, 2021

Reckitt Benckiser Group (RB) has agreed to acquire the Biofreeze topical pain relief brand from Madison Dearborn Partners subsidiary Performance Health for an undisclosed price. ... Read More

Bexson Biomedical raises $4.8m in Series A round for subcutaneous ketamine treatment platform

pharmanewsdaily- February 3, 2021

Bexson Biomedical has raised $4.8 million in a Series A financing round for developing a subcutaneous ketamine treatment platform for pain management and mental health ... Read More